UPLOAD Filing
Cadrenal Therapeutics, Inc.
Date: April 27, 2026 · CIK: 0001937993 · Accession: 0000000000-26-004261
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295200
Letter
April 27, 2026 Quang Pham Chairman and Chief Executive Officer Cadrenal Therapeutics, Inc. 822 A1A North, Suite 306 Ponte Vedra, FL 32082 Re: Cadrenal Therapeutics, Inc. Registration Statement on Form S-3 Filed April 21, 2026 File No. 333-295200 Dear Quang Pham: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Leslie Marlow, Esq.
Show Raw Text
April 27, 2026
Quang Pham
Chairman and Chief Executive Officer
Cadrenal Therapeutics, Inc.
822 A1A North, Suite 306
Ponte Vedra, FL 32082
Re: Cadrenal Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 21, 2026
File No. 333-295200
Dear Quang Pham:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Leslie Marlow, Esq.